trimegestone has been researched along with mifepristone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benhamou, B; Gofflo, D; Guillot, B; Moras, D; Ossart, C; Philibert, D; Robin-Jagerschmidt, C; Vergezac, A; Wurtz, JM | 1 |
Al-Azzawi, F; Pringle, JH; Taylor, AH; Thompson, J; Wahab, M | 1 |
2 other study(ies) available for trimegestone and mifepristone
Article | Year |
---|---|
Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Furylfuramide; Glucocorticoids; Hormone Antagonists; Humans; Hydroxycorticosteroids; Mifepristone; Models, Molecular; Molecular Sequence Data; Progestins; Promegestone; Protein Conformation; Receptors, Glucocorticoid; Receptors, Progesterone; Recombinant Proteins; Sequence Homology, Amino Acid; Substrate Specificity; Transcriptional Activation | 2000 |
Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell.
Topics: Adult; Cells, Cultured; Dose-Response Relationship, Drug; Endometrium; Estradiol; Female; Humans; Immunohistochemistry; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Menstruation; Middle Aged; Mifepristone; Progesterone; Progestins; Promegestone; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stromal Cells | 2006 |